The patient.
When any type of cancer metastasizes and spreads to the bone or other organs, this is very serious. Only a trained doctor who looks at the pathology of patient who has cancer that has spread to the bone can make such a diagnosis.
A bone survey can help assess the extent of cancer in the bones by detecting any signs of tumors, fractures, or other abnormalities. This information is crucial for understanding the stage of the cancer and guiding treatment decisions for the patient.
One of the biggest factors that determines a patient's bone cancer prognosis is the current stage of the disease. If the bone cancer has metastasized to the lymph nodes, or other areas of the body, the cancer will be harder to successfully treat, resulting in a shorter survival rate. Five-year survival-rate statistics help a physician calculate a particular patient's bone cancer prognosis. Male, Caucasian adults have the worst survival rate while female, Caucasian adults have the best survival rate. The five-year bone cancer survival rates range from 67-74 percent when averaging all races.
Yes, bone cancer is a rare type of cancer that begins in the bone tissue. It can either originate in the bone itself (primary bone cancer) or spread to the bone from another part of the body (secondary or metastatic bone cancer). Treatment may involve surgery, chemotherapy, and radiation therapy.
If the patient opts for chemotherapy, they might live for 18 to 24 months. With no chemo, 8 or 9 months. Everyone is different, but this is the average.
Bone marrow is taken out and stored for some time. After treatment, which could be chemotherapy or radiotherapy, the stored bone marrow is returned to the patient. This procedure is carried out during treatment of cancer, Hodgkin's or leukemia and is called autologous bone marrow transplant
A patient dog eat the fattest bone
Bone cancer is noncommunicable disease.
Leukemia is a cancer of the bone marrow.
To a bone cancer specialist.
Actually, the opposite is true. Approximately 80% of bone cancers are secondary, such as metastasis from primary tumors in soft tissue. Only about 20% of bone cancers actually start in the bone and then metastasize to soft tissues and other locations.